2018
DOI: 10.1016/j.heliyon.2018.e00697
|View full text |Cite
|
Sign up to set email alerts
|

A feasibility randomised controlled trial to evaluate the effectiveness of a novel neuromuscular electro-stimulation device in preventing the formation of oedema following total hip replacement surgery

Abstract: AimThe aim of this feasibility study was to investigate the potential role of a novel neuromuscular electrical stimulation (NMES) device in preventing the formation of oedema following total hip replacement (THR).MethodsSuccessive primary THR patients were recruited into a randomised controlled trial. Participants were randomised to wear either the NMES device or compression stockings continually from post-surgery until discharge.The main outcome measure was presence of lower limb oedema, assessed by taking me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0
1

Year Published

2018
2018
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 17 publications
0
9
0
1
Order By: Relevance
“…Neuromuscular electrical stimulation (NMES) devices are reported to reduce oedema by compressing venous and lymphatic vessels and inducing an increase in venous return and lymphatic flow; 9 however, they are not currently used during routine treatment following an ankle sprain. Preliminary work has found NMES to facilitate a reduction in oedema in other populations, 10,11 and therefore, this pilot study aims to assess the feasibility of a larger trial to determine whether NMES (firefly™ manufactured by Firstkind Ltd., High Wycombe, UK) could help to reduce oedema in ankle sprain patients when used in addition to standard care.…”
Section: Introductionmentioning
confidence: 99%
“…Neuromuscular electrical stimulation (NMES) devices are reported to reduce oedema by compressing venous and lymphatic vessels and inducing an increase in venous return and lymphatic flow; 9 however, they are not currently used during routine treatment following an ankle sprain. Preliminary work has found NMES to facilitate a reduction in oedema in other populations, 10,11 and therefore, this pilot study aims to assess the feasibility of a larger trial to determine whether NMES (firefly™ manufactured by Firstkind Ltd., High Wycombe, UK) could help to reduce oedema in ankle sprain patients when used in addition to standard care.…”
Section: Introductionmentioning
confidence: 99%
“…Graduated compression stockings are not pressure-controlled, and rely on the correct measurement on the limb dimensions, the correct choice of garment size, the correct application of the stocking, and the 'normal' shape of the limb. 49,54 Electrical stimulation devices may require correct positioning 55 and output adjustment 56 to achieve a significant haemodynamic effect. Variability in the application of devices can affect multi-centre trials, and further complicate meta-analyses and comparisons between trials.…”
Section: Application and Monitoring Of The Devicementioning
confidence: 99%
“…10 NMES has also been shown to reduce oedema in patients with lymphedema, 11 and in patients following total hip replacement surgery. 12 NMES has been used successfully to treat hard-to-heal leg ulcers 13,14 and has been shown to promote a significant increase in leg ulcer healing rate. 15 This is a single centre open label study measuring the effect of neuromuscular stimulation on lower limb arterial and venous blood flow in patients with venous leg ulcers.…”
Section: Introductionmentioning
confidence: 99%